Received May 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MEN | MENINGOCOCCAL (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
(plates tanked to zero after the Meningitis B shot).; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of platelet count decreased in a patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis. The patient's past medical history included post herpetic neuralgia and hemoglobin decreased. Previously administered products included Soliris. On an unknown date, the patient received Meningococcal B vaccine. On an unknown date, an unknown time after receiving Meningococcal B vaccine, the patient experienced platelet count decreased (Verbatim: (plates tanked to zero after the Meningitis B shot).). The outcome of the platelet count decreased was not reported. It was unknown if the reporter considered the platelet count decreased to be related to Meningococcal B vaccine. It was unknown if the company considered the platelet count decreased to be related to Meningococcal B vaccine. Additional Information: GSK Receipt ate:21-MAY-2025 The reporter was a patient with PNH. The reporter had hemoglobin counts of less than 5 a few times and dozens of blood transfusions, tried Soliris and Ultamiris, was injured by the vaccine required to take those treatments (plates tanked to zero after the Meningitis B shot). The patient then received platelet.
Medical History/Concurrent Conditions: Hemoglobin decreased; Post herpetic neuralgia